MX2015009914A - Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. - Google Patents

Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Info

Publication number
MX2015009914A
MX2015009914A MX2015009914A MX2015009914A MX2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A MX 2015009914 A MX2015009914 A MX 2015009914A
Authority
MX
Mexico
Prior art keywords
blood collection
inhibitor
collection devices
devices containing
contact pathway
Prior art date
Application number
MX2015009914A
Other languages
English (en)
Spanish (es)
Inventor
Keith A Moskowitz
Frank L Sinquett
Original Assignee
Becton Dickinson Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Becton Dickinson Co filed Critical Becton Dickinson Co
Publication of MX2015009914A publication Critical patent/MX2015009914A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
    • B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
    • B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
    • B01L3/5021—Test tubes specially adapted for centrifugation purposes
    • B01L3/50215—Test tubes specially adapted for centrifugation purposes using a float to separate phases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/06—Ampoules or carpules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/1406—Septums, pierceable membranes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/042—Caps; Plugs
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
    • B01L2300/00—Additional constructional details
    • B01L2300/04—Closures and closing means
    • B01L2300/041—Connecting closures to device or container
    • B01L2300/044—Connecting closures to device or container pierceable, e.g. films, membranes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Environmental Sciences (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Dentistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Clinical Laboratory Science (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Physiology (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Materials For Medical Uses (AREA)
MX2015009914A 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto. MX2015009914A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361759742P 2013-02-01 2013-02-01
PCT/US2014/014089 WO2014121041A1 (en) 2013-02-01 2014-01-31 Blood collection devices containing contact pathway inhibition additives

Publications (1)

Publication Number Publication Date
MX2015009914A true MX2015009914A (es) 2015-09-25

Family

ID=51259520

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015009914A MX2015009914A (es) 2013-02-01 2014-01-31 Dispositivos de recogida de sangre que contienen aditivos de inhibicion de la via de contacto.

Country Status (12)

Country Link
US (1) US20140220552A1 (cg-RX-API-DMAC10.html)
EP (1) EP2950718A4 (cg-RX-API-DMAC10.html)
JP (1) JP2016505159A (cg-RX-API-DMAC10.html)
KR (1) KR20150141940A (cg-RX-API-DMAC10.html)
CN (1) CN105188535A (cg-RX-API-DMAC10.html)
AU (1) AU2014212194A1 (cg-RX-API-DMAC10.html)
BR (1) BR112015018077A2 (cg-RX-API-DMAC10.html)
CA (1) CA2899594A1 (cg-RX-API-DMAC10.html)
MX (1) MX2015009914A (cg-RX-API-DMAC10.html)
RU (1) RU2015136025A (cg-RX-API-DMAC10.html)
SG (1) SG11201505978PA (cg-RX-API-DMAC10.html)
WO (1) WO2014121041A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4234583A3 (en) 2013-01-20 2024-01-24 Takeda Pharmaceutical Company Limited Evaluation and treatment of bradykinin-mediated disorders
CN110658337B (zh) 2013-10-21 2023-06-16 武田药品工业株式会社 自身免疫性疾病的诊断和治疗
CN105873951A (zh) 2013-10-21 2016-08-17 戴埃克斯有限公司 用于确定血浆激肽释放酶系统生物标记的试验
WO2016180990A1 (en) * 2015-05-14 2016-11-17 General Electric Company Device for separation and collection of plasma
ES2938089T3 (es) 2015-08-13 2023-04-04 Takeda Pharmaceuticals Co Tubos de extracción de sangre al vacío que contienen inhibidores de proteasa para la evaluación de la activación del sistema de contacto
EA201891002A1 (ru) * 2015-10-19 2018-11-30 Дайэкс Корп. Иммунологический анализ для определения расщепленного высокомолекулярного кининогена
WO2017119508A1 (ja) * 2016-01-07 2017-07-13 藤森工業株式会社 採血管、試薬及びそれらを利用した血液性状分析方法
CN108342381A (zh) * 2017-01-24 2018-07-31 梁建国 一种用于稳定保存外周血中循环游离dna的溶剂
JP7649105B2 (ja) * 2017-07-21 2025-03-19 アムジエン・インコーポレーテツド 薬物容器のためのガス透過性シーリング部材及び組立方法
US12485412B2 (en) * 2021-08-05 2025-12-02 Lance Liberti Kit including biotin for harvesting platelet-rich plasma
CN115555070B (zh) * 2022-10-18 2024-11-05 北京积水潭医院 一种prf离心管
GB202219505D0 (en) * 2022-12-22 2023-02-08 Turzi Antoine Medical composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002517739A (ja) * 1998-06-08 2002-06-18 ユニバーシティ オブ バーモント アンド ステイト アグリカルチャー カレッジ 血液および血液製剤における凝固の抑制
US20030064414A1 (en) * 2001-03-30 2003-04-03 Benecky Michael J. Rapid assessment of coagulation activity in whole blood
CN102353569A (zh) * 2002-05-13 2012-02-15 贝克顿·迪金森公司 蛋白酶抑制剂样品采集系统
US8603345B2 (en) * 2003-02-13 2013-12-10 Becton, Dickinson And Company Devices for component removal during blood collection, and uses thereof
WO2005017486A2 (en) * 2003-06-09 2005-02-24 Mann Kenneth G A global test of the hemostatic system
GB0711779D0 (en) * 2007-06-18 2007-07-25 Univ Singapore Thrombin inhibitor
CA2705851C (en) * 2007-11-21 2016-11-01 Oregon Health & Science University Anti-factor xi monoclonal antibodies and methods of use thereof
JP5937612B2 (ja) * 2010-12-02 2016-06-22 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 血液安定剤を含む採血用デバイス
CN103415301A (zh) * 2011-03-09 2013-11-27 德国杰特贝林生物制品有限公司 用于与包括与人造表面接触的医疗操作一起施用的fxii抑制剂

Also Published As

Publication number Publication date
CN105188535A (zh) 2015-12-23
BR112015018077A2 (pt) 2017-07-18
US20140220552A1 (en) 2014-08-07
AU2014212194A1 (en) 2015-09-17
CA2899594A1 (en) 2014-08-07
SG11201505978PA (en) 2015-08-28
EP2950718A1 (en) 2015-12-09
EP2950718A4 (en) 2016-09-21
RU2015136025A (ru) 2017-03-06
JP2016505159A (ja) 2016-02-18
WO2014121041A1 (en) 2014-08-07
KR20150141940A (ko) 2015-12-21

Similar Documents

Publication Publication Date Title
BR112015018077A2 (pt) dispositivos de coleta de sangue que contêm aditivos de inibição de trajeto de contato
NI201500103A (es) Anticuerpos cd47 que no agotan plaquetas ni glóbulos rojos y métodos de uso de los mismos.
CL2018003282A1 (es) Métodos y composiciones para el tratamiento de cánceres resistentes a los inhibidores de la vía no erk mapk
MX2016013963A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
CO2018000631A2 (es) Compuestos bicíclicos como inhibidores de atx
MX380146B (es) Inhibidores mk2 y usos de los mismos.
MX2018003353A (es) Terapias con celulas cart con una eficacia mejorada.
DOP2015000269A (es) Composiciones y métodos para alterar la señalización del segundo mensajero
MX2016007972A (es) Metodos para tratar canceres con antagonistas de union al eje pd-1 y taxanos.
MD20150100A2 (ro) Virusurile bolii de Newcastle şi utilizarea acestora
CR20160419A (es) Nuevos compuestos biciclicos
AR097481A1 (es) Cocristales energéticos para el tratamiento de una formación subterránea
EA201690582A1 (ru) Модуляторы фактора в комплемента
UY34234A (es) Inhibidores de la replicación de los virus de la gripe
CL2016000241A1 (es) Formulación de inhibidores de la syk.
DOP2013000260A (es) Uso del anticuerpo anti-cd19 inmunoconjugado con maitansinoide para el tratamiento del síntoma tumores de células b
CR20150277A (es) Piridina-2-amidas utiles como agonistas cb2
CL2018000649A1 (es) Nuevos compuestos bicíclicos como inhibidores duales de atx / ca
MX2016002423A (es) Composiciones y metodos de diagnostico para el tratamiento de glioblastoma.
MX355951B (es) Sistemas y metodos para asignacion dinamica para localidad y equilibrio.
CY1117414T1 (el) Παραγοντες αναστροφης αντιπηκτικου
UY34132A (es) Terapias combinadas para el tratamiento de neoplasias malignas hematológicas utilizando inhibidores de piridopirimidinona de pi3k/mtor con bendamustina y/o rituximab.
UY37258A (es) AGENTES REVERSORES DE UNIÓN PARA ANTICUERPOS ANTI-FACTOR XI/XIa Y SUS USOS
CR20150440A (es) Nuevos derivados de piridina
CL2016001266A1 (es) Nuevo octahidro-ciclobuta[1,2-c;3,4-c']dipirrol-2-ilo.